EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Wnt Signaling Inhibitors as Therapeutic Approach in Ischemic Heart Disease

Barbora Boťanská Svetláková, Viktória Pecníková Líšková, Miroslav Barančík

Molecules · 17.12.2024 · 29 (24) · 5958

DOI: 10.3390/molecules29245958 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 17.12.2024. Verfasst von Barbora Boťanská Svetláková und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Experimental Medicine, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Myocardial Ischemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Academy of Sciences, Agency for Research and Development, VEGA SR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wnt (wingless-type MMTV integration site family) signaling is an evolutionary conserved system highly active during embryogenesis, but in adult hearts has low activities under normal conditions. It is essential for a variety of physiological processes including stem cell regeneration, proliferation, migration, cell polarity, and morphogenesis, thereby ensuring homeostasis and regeneration of cardiac tissue. Its dysregulation and excessive activation during pathological conditions leads to morphological and functional changes in the heart resulting in impaired myocardial regeneration under pathological conditions such as myocardial infarction, heart failure, and coronary artery disease. Several groups of Wnt inhibitors have demonstrated the ability to modulate the Wnt pathway and thereby significantly reduce fibrosis and improve cardiac function after myocardial ischemia. Their inhibitory effect can be realized at multiple levels, which include the inhibition of Wnt ligands, the inhibition of Frizzled receptors, the stabilization of the β-catenin destruction complex, and the disruption of nuclear β-catenin interactions. In this review, we overview the function of Wnt signaling in responses of cardiac cells to pathological conditions, especially ischemic heart disease, with an emphasis on the use of inhibitors of this signaling as a therapeutic approach. Finally, we summarize the current knowledge about the potential of the targeting of Wnt signaling in therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wnt Signaling PathwayMyocardial IschemiaHumansAnimalsWnt ProteinsFrizzled Receptors

Stichwörter der Autor:innen

Wnt inhibitorsWnt signalingfibrosismyocardial ischemiapathological remodelingβ-catenin

Substanzen

Wnt ProteinsFrizzled Receptors

Autor:innen und Institutionen

  • Centre of Experimental Medicine, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.

Förderung

  • Slovak Academy of Sciences
  • Agency for Research and Development
  • VEGA SR
  • Postdoc

Zitieren

APA

Svetláková, B. B., Líšková, V. P., & Barančík, M. (2024). Wnt Signaling Inhibitors as Therapeutic Approach in Ischemic Heart Disease. Molecules, 29(24), 5958. https://doi.org/10.3390/molecules29245958

Vancouver

Svetláková BB, Líšková VP, Barančík M. Wnt Signaling Inhibitors as Therapeutic Approach in Ischemic Heart Disease. Molecules. 2024;29(24):5958. doi:10.3390/molecules29245958

BibTeX
@article{Svetlkov2024,
  author = {Svetláková, Barbora Boťanská and Líšková, Viktória Pecníková and Barančík, Miroslav},
  title = {Wnt Signaling Inhibitors as Therapeutic Approach in Ischemic Heart Disease},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {24},
  pages = {5958},
  doi = {10.3390/molecules29245958}
}
Kostenlos starten →